Gut microbiota-bone axis

Critical Reviews in Food Science and Nutrition

Volumn 57, Issue 8, 2017, Pages 1664-1672

  Villa, Christopher R ^a   Ward, Wendy E ^a,b   Comelli, Elena M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b BROCK UNIVERSITY   (Canada)

Author keywords

aging; bone mineral density; bone structure; Development; probiotics

Indexed keywords

AGING OF MATERIALS; BACTERIA; HEALTH; MICROORGANISMS; SYNTHESIS (CHEMICAL);

BONE MINERAL DENSITY; BONE STRUCTURE; CLINICAL INTERVENTIONS; DEVELOPMENT; MICROBIAL COMMUNITIES; POTENTIAL MECHANISM; PROBIOTICS; SEX-SPECIFIC DIFFERENCES;

BONE;

PROBIOTIC AGENT;

ANIMAL; BONE; DISEASE MODEL; HOMEOSTASIS; HUMAN; INTESTINE; INTESTINE FLORA; LACTOBACILLUS; MICROBIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANIMALS; BONE AND BONES; DISEASE MODELS, ANIMAL; GASTROINTESTINAL MICROBIOME; HOMEOSTASIS; HUMANS; INTESTINES; LACTOBACILLUS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85015243243     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2015.1010034     Document Type: Article

References (110)

1. Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis. (1994). WHO technical report series Geneva.
2. Adlerberth, I., and Wold, A. E., (2009). Establishment of the gut microbiota in Western infants. Acta Paediatr. 98:229–238.
3. Akesson, K., Marsh, D., Mitchell, P. J., et al. (2013). Capture the Fracture:A Best Practice Framework and global campaign to break the fragility fracture cycle. Osteoporos. Int. 24:2135–2152.
4. Arai, F., Miyamoto, T., Ohneda, O., et al. (1999). Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J. Exp. Med. 190:1741–1754.
5. Avella, M. A., Place, A., Du, S. J., et al. (2012). Lactobacillus rhamnosus accelerates zebrafish backbone calcification and gonadal differentiation through effects on the GnRH and IGF systems. PLoS One. 7:e45572.
6. Avershina, E., Storro, O., Oien, T., et al. (2014). Major faecal microbiota shifts in composition and diversity with age in a geographically restricted cohort of mothers and their children. FEMS Microbiol. Ecol. 87:280–290.
7. Backhed, F., Ding, H., Wang, T., et al. (2004). The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA. 101:15718–15723.
8. Backhed, F., Fraser, C. M., Ringel, Y., et al. (2012). Defining a healthy human gut microbiome:Current concepts, future directions, and clinical applications. Cell Host. Microbe. 12:611–622.
9. Baird, J., Kurshid, M. A., Kim, M., et al. (2011). Does birthweight predict bone mass in adulthood? A systematic review and meta-analysis. Osteoporos. Int. 22:1323–1334.
10. Biagi, E., Nylund, L., Candela, M., et al. (2010). Through ageing, and beyond:Gut microbiota and inflammatory status in seniors and centenarians. PLoS One. 5:e10667.
11. Bliziotes, M., Eshleman, A., Burt-Pichat, B., et al. (2006). Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells. Bone. 39:1313–1321.
12. Boyle, W. J., Simonet, W. S., and Lacey, D. L., (2003). Osteoclast differentiation and activation. Nature. 423:337–342.
13. Britton, R. A., Irwin, R., Quach, D., et al. (2014). Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model. J. Cell. Physiol.
14. Campbell, J. M., Fahey, G. C., Jr., Wolf, B. W., (1997). Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. J. Nutr. 127:130–136.
15. Cani, P. D., Amar, J., Iglesias, M. A., et al. (2007a). Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 56:1761–1772.
16. Cani, P. D., Neyrinck, A. M., Fava, F., et al. (2007b). Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 50:2374–2383.
17. Chen, D., and Zhao, C. M., (2011). The possible existence of a gut-bone axis suggested by studies of genetically manipulated mouse models? Curr. Pharm. Des. 17:1552–1555.
18. Chiang, S. S., and Pan, T. M., (2011). Antiosteoporotic effects of Lactobacillus -fermented soy skim milk on bone mineral density and the microstructure of femoral bone in ovariectomized mice. J. Agric. Food Chem. 59:7734–7742.
19. Chonan, O., Matsumoto, K., and Watanuki, M., (1995). Effect of galactooligosaccharides on calcium absorption and preventing bone loss in ovariectomized rats. Biosci. Biotechnol. Biochem. 59:236–239.
20. Chonan, O., and Watanuki, M., (1996). The effect of 6′-galactooligosaccharides on bone mineralization of rats adapted to different levels of dietary calcium. Int. J. Vitam. Nutr. Res. 66:244–249.
21. Claesson, M. J., Jeffery, I. B., Conde, S., et al. (2012). Gut microbiota composition correlates with diet and health in the elderly. Nature. 488:178–184.
22. Cote, F., Thevenot, E., Fligny, C., et al. (2003). Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function. Proc. Natl. Acad. Sci. USA. 100:13525–13530.
23. Cui, Y., Niziolek, P. J., MacDonald, B. T., et al. (2011). Lrp5 functions in bone to regulate bone mass. Nat. Med. 17:684–691.
24. Czerwinski, E., Badurski, J. E., Marcinowska-Suchowierska, E., et al. (2007). Current understanding of osteoporosis according to the position of the World Health Organization (WHO) and International Osteoporosis Foundation. Ortop. Traumatol. Rehabil. 9:337–356.
25. De Palma, G., Nadal, I., Medina, M., et al. (2010). Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol. 10:63.
26. Dial, S., Alrasadi, K., Manoukian, C., et al. (2004). Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors:Cohort and case-control studies. CMAJ. 171:33–38.
27. Dixon, D. R., and Darveau, R. P., (2005). Lipopolysaccharide heterogeneity:Innate host responses to bacterial modification of lipid a structure. J. Dent. Res. 84:584–595.
28. Dobber, R., Hertogh-Huijbregts, A., Rozing, J., et al. (1992). The involvement of the intestinal microflora in the expansion of CD4+ T cells with a naive phenotype in the periphery. Dev. Immunol. 2:141–150.
29. Engelbregt, M. J., van Weissenbruch, M. M., Lips, P., et al. (2004). Body composition and bone measurements in intra-uterine growth retarded and early postnatally undernourished male and female rats at the age of 6 months:Comparison with puberty. Bone. 34:180–186.
30. Faith, J. J., Guruge, J. L., Charbonneau, M., et al. (2013). The long-term stability of the human gut microbiota. Science. 341:1237439.
31. Fanca-Berthon, P., Hoebler, C., Mouzet, E., et al. (2010). Intrauterine growth restriction not only modifies the cecocolonic microbiota in neonatal rats but also affects its activity in young adult rats. J. Pediatr. Gastroenterol. Nutr. 51:402–413.
32. FAO/WHO. (2001). Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria 2001.
33. Favier, C. F., Vaughan, E. E., De Vos, W. M., et al. (2002). Molecular monitoring of succession of bacterial communities in human neonates. Appl. Environ. Microbiol. 68:219–226.
34. Frank, D. N., St Amand, A. L., Feldman, R. A., et al. (2007). Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA. 104:13780–13785.
35. Furet, J. P., Kong, L. C., Tap, J., et al. (2010). Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss:Links with metabolic and low-grade inflammation markers. Diabetes. 59:3049–3057.
36. Gershon, M. D., and Tack, J., (2007). The serotonin signaling system:From basic understanding to drug development for functional GI disorders. Gastroenterology. 132:397–414.
37. Gosalbes, M. J., Llop, S., Valles, Y., et al. (2013). Meconium microbiota types dominated by lactic acid or enteric bacteria are differentially associated with maternal eczema and respiratory problems in infants. Clin. Exp. Allergy. 43:198–211.
38. Greco, E. A., Fornari, R., Rossi, F., et al. (2010). Is obesity protective for osteoporosis? Evaluation of bone mineral density in individuals with high body mass index. Int. J. Clin. Pract. 64:817–820.
39. Gupta, S., and Shen, B., (2013). Bone loss in patients with the ileostomy and ileal pouch for inflammatory bowel disease. Gastroenterol. Rep. (Oxf). 1:159–165.
40. Harvey, N., Dennison, E., and Cooper, C., (2014). Osteoporosis—A lifecourse approach. J. Bone Miner. Res.
41. Hernandez, C. J., Beaupre, G. S., and Carter, D. R., (2003). A theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis. Osteoporos. Int. 14:843–847.
42. Hill, C., Guarner, F., Reid, G., et al. (2014). Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11:506–514.
43. Holzapfel, W. H., Haberer, P., Snel, J., et al. (1998). Overview of gut flora and probiotics. Int. J. Food Microbiol. 41:85–101.
44. Inose, H., Zhou, B., Yadav, V. K., et al. (2011). Efficacy of serotonin inhibition in mouse models of bone loss. J. Bone Miner. Res. 26:2002–2011.
45. Javaid, M. K., Crozier, S. R., Harvey, N. C., et al. (2006). Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years:A longitudinal study. Lancet. 367:36–43.
46. Johnell, O., (1997). The socioeconomic burden of fractures:Today and in the 21st century. Am. J. Med. 103:20S–25S; discussion 25S–26S.
47. Johnell, O., and Kanis, J. A., (2006). An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos. Int. 17:1726–1733.
48. Kajiya, M., Giro, G., Taubman, M. A., et al. (2010). Role of periodontal pathogenic bacteria in RANKL-mediated bone destruction in periodontal disease. J. Oral. Microbiol. 2.
49. Kalliomaki, M., Collado, M. C., Salminen, S., et al. (2008). Early differences in fecal microbiota composition in children may predict overweight. Am. J. Clin. Nutr. 87:534–538.
50. Kao, C., and Levytam, S., (2009). The Role of the ‘eubiotic’ diet in intestinal dysbiosis and hypertension. International Journal of Naturopathic Medicine 4:42–49.
51. Kelly, C. J., Colgan, S. P., and Frank, D. N., (2012). Of microbes and meals:The health consequences of dietary endotoxemia. Nutr. Clin. Pract. 27:215–225.
52. Kim, J. H., Choi, H. J., Kim, M. J., et al. (2012). Fat mass is negatively associated with bone mineral content in Koreans. Osteoporos. Int. 23:2009–2016.
53. Kimoto-Nira, H., Suzuki, C., Kobayashi, M., et al. (2007). Anti-ageing effect of a lactococcal strain:Analysis using senescence-accelerated mice. Br. J. Nutr. 98:1178–1186.
54. Lan, G. Q., Abdullah, N., Jalaludin, S., et al. (2002). Efficacy of supplementation of a phytase-producing bacterial culture on the performance and nutrient use of broiler chickens fed corn-soybean meal diets. Poult. Sci. 81:1522–1532.
55. Ley, R. E., Backhed, F., Turnbaugh, P., et al. (2005). Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA. 102:11070–11075.
56. Ley, R. E., Turnbaugh, P. J., Klein, S., et al. (2006). Microbial ecology:Human gut microbes associated with obesity. Nature. 444:1022–1023.
57. Liu, D., Xu, J. K., Figliomeni, L., et al. (2003). Expression of RANKL and OPG mRNA in periodontal disease:Possible involvement in bone destruction. Int. J. Mol. Med. 11:17–21.
58. Lorenzo, J., Horowitz, M., and Choi, Y., (2008). Osteoimmunology:Interactions of the bone and immune system. Endocr. Rev. 29:403–440.
59. Mackie, R. I., Sghir, A., and Gaskins, H. R., (1999). Developmental microbial ecology of the neonatal gastrointestinal tract. Am. J. Clin. Nutr. 69:1035S–1045S.
60. Macpherson, A. J., and Harris, N. L., (2004). Interactions between commensal intestinal bacteria and the immune system. Nat. Rev. Immunol. 4:478–485.
61. Manichanh, C., Rigottier-Gois, L., Bonnaud, E., et al. (2006). Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 55:205–211.
62. Maradonna, F., Gioacchini, G., Falcinelli, S., et al. (2013). Probiotic supplementation promotes calcification in Danio rerio larvae:A molecular study. PLoS One. 8:e83155.
63. Mariat, D., Firmesse, O., Levenez, F., et al. (2009). The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 9:123.
64. Markle, J. G., Frank, D. N., Mortin-Toth, S., et al. (2013). Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science. 339:1084–1088.
65. Martel, F., (2006). Recent advances on the importance of the serotonin transporter SERT in the rat intestine. Pharmacol. Res. 54:73–76.
66. Mazmanian, S. K., Liu, C. H., Tzianabos, A. O., et al. (2005). An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 122:107–118.
67. McCabe, L. R., Irwin, R., Schaefer, L., et al. (2013). Probiotic use decreases intestinal inflammation and increases bone density in healthy male but not female mice. J. Cell. Physiol. 228:1793–1798.
68. Moles, L., Gomez, M., Heilig, H., et al. (2013). Bacterial diversity in meconium of preterm neonates and evolution of their fecal microbiota during the first month of life. PLoS One. 8:e66986.
69. Mosca, L. N., Goldberg, T. B., da Silva, V. N., et al. (2014). Excess body fat negatively affects bone mass in adolescents. Nutrition. 30:847–852.
70. Mutus, R., Kocabagli, N., Alp, M., et al. (2006). The effect of dietary probiotic supplementation on tibial bone characteristics and strength in broilers. Poult. Sci. 85:1621–1625.
71. Nadal, I., Donat, E., Ribes-Koninckx, C., et al. (2007). Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J. Med. Microbiol. 56:1669–1674.
72. Noor, S. O., Ridgway, K., Scovell, L., et al. (2010). Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol. 10:134.
73. Ohlsson, C., Engdahl, C., Fak, F., et al. (2014). Probiotics protect mice from ovariectomy-induced cortical bone loss. PLoS One. 9:e92368.
74. Palmer, C., Bik, E. M., DiGiulio, D. B., et al. (2007). Development of the human infant intestinal microbiota. PLoS Biol. 5:e177.
75. Park, H. K., Shim, S. S., Kim, S. Y., et al. (2005). Molecular analysis of colonized bacteria in a human newborn infant gut. J. Microbiol. 43:345–3453.
76. Pineiro, M., Asp, N. G., Reid, G., et al. (2008). FAO Technical meeting on prebiotics. J. Clin. Gastroenterol. 42(Suppl 3 Pt 2):S156–S159.
77. Rawls, J. F., Mahowald, M. A., Ley, R. E., et al. (2006). Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell. 127:423–433.
78. Sadeghi, A. A., (2014). Bone mineralization of broiler chicks challenged with Salmonella enteritidis fed diet containing probiotic (Bacillus subtilis). Probiotics Antimicrob Proteins. 6:136–140.
79. Savage, D. C., (1977). Microbial ecology of the gastrointestinal tract. Annu. Rev. Microbiol. 31:107–133.
80. Sjogren, K., Engdahl, C., Henning, P., et al. (2012). The gut microbiota regulates bone mass in mice. J. Bone Miner. Res. 27:1357–1367.
81. Sokol, H., Pigneur, B., Watterlot, L., et al. (2008). Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. USA. 105:16731–16736.
82. Taverniti, V., and Guglielmetti, S., (2011). The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics:Proposal of paraprobiotic concept). Genes. Nutr. 6:261–274.
83. Tobias, J. H., Steer, C. D., Emmett, P. M., et al. (2005). Bone mass in childhood is related to maternal diet in pregnancy. Osteoporos. Int. 16:1731–1741.
84. Tsilingiri, K., and Rescigno, M., (2013). Postbiotics:What else? Benef. Microbes. 4:101–107.
85. Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., et al. (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 444:1027–1031.
86. Turnbaugh, P. J., Backhed, F., Fulton, L., et al. (2008). Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host. Microbe. 3:213–223.
87. Turnbaugh, P. J., Hamady, M., Yatsunenko, T, et al. (2009). A core gut microbiome in obese and lean twins. Nature. 457:480–484.
88. Valles, Y., Artacho, A., Pascual-Garcia, A., et al. (2014). Microbial succession in the gut:Directional trends of taxonomic and functional change in a birth cohort of Spanish infants. PLoS Genet. 10:e1004406.
89. van den Heuvel, E. G., Schoterman, M. H., and Muijs, T., (2000). Transgalactooligosaccharides stimulate calcium absorption in postmenopausal women. J. Nutr. 130:2938–2942.
90. Vestergaard, P., Krogh, K., Rejnmark, L., et al. (2000). Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut. 46:176–181.
91. Voth, D. E., and Ballard, J. D., (2005). Clostridium difficile toxins:Mechanism of action and role in disease. Clin. Microbiol. Rev. 18:247–263.
92. Vrieze, A., Holleman, F., Zoetendal, E. G., et al. (2010). The environment within:How gut microbiota may influence metabolism and body composition. Diabetologia. 53:606–613.
93. Wade, P. R., Chen, J., Jaffe, B., et al. (1996). Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract. J. Neurosci. 16:2352–2364.
94. Walther, D. J., Peter, J. U., Bashammakh, S., et al. (2003). Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science. 299:76.
95. Wang, M., Ahrne, S., Antonsson, M., et al. (2004). T-RFLP combined with principal component analysis and 16S rRNA gene sequencing:An effective strategy for comparison of fecal microbiota in infants of different ages. J. Microbiol. Methods. 59:53–69.
96. Weaver, C. M., Martin, B. R., Nakatsu, C. H., et al. (2011). Galactooligosaccharides improve mineral absorption and bone properties in growing rats through gut fermentation. J. Agric. Food Chem. 59:6501–6510.
97. Wei, S., Kitaura, H., Zhou, P., et al. (2005). IL-1 mediates TNF-induced osteoclastogenesis. J. Clin. Invest. 115:282–290.
98. Whisner, C. M., Martin, B. R., Schoterman, M. H., et al. (2013). Galacto-oligosaccharides increase calcium absorption and gut bifidobacteria in young girls:A double-blind cross-over trial. Br. J. Nutr. 110:1292–1303.
99. WHO. (1994). Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. [No authors listed]. World Health Organ Tech Rep Ser. 843:1–129. PMID:7941614. Available at https://www.ncbi.nlm.nih.gov/pubmed/7941614
100. Xu, D. X., Chen, Y. H., Wang, H., et al. (2006). Tumor necrosis factor alpha partially contributes to lipopolysaccharide-induced intra-uterine fetal growth restriction and skeletal development retardation in mice. Toxicol. Lett. 163:20–29.
101. Xu, J., and Gordon, J. I., (2003). Honor thy symbionts. Proc. Natl. Acad. Sci. USA. 100:10452–10459.
102. Yadav, V. K., Ryu, J. H., Suda, N., et al. (2008). Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell. 135:825–837.
103. Yadav, V. K., Balaji, S., Suresh, P. S., et al. (2010). Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nat. Med. 16:308–312.
104. Yang, R. B., Mark, M. R., Gray, A., et al. (1998). Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature. 395:284–288.
105. Yarilina, A., Xu, K., Chen, J., et al. (2011). TNF activates calcium-nuclear factor of activated T cells (NFAT)c1 signaling pathways in human macrophages. Proc. Natl. Acad. Sci. USA. 108:1573–1578.
106. Yatsunenko, T., Rey, F. E., Manary, M. J., et al. (2012). Human gut microbiome viewed across age and geography. Nature. 486:222–227.
107. Yearsley, K. A., Gilby, L. J., Ramadas, A. V., et al. (2006). Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea. Aliment. Pharmacol. Ther. 24:613–619.
108. Yin, J., Dwyer, T., Riley, M., et al. (2010). The association between maternal diet during pregnancy and bone mass of the children at age 16. Eur. J. Clin. Nutr. 64:131–137.
109. Yoo, H. J., Park, M. S., Yang, S. J., et al. (2012). The differential relationship between fat mass and bone mineral density by gender and menopausal status. J. Bone Miner. Metab. 30:47–53.
110. Zhang, M., Qiu, X., Zhang, H., et al. (2014). Faecalibacterium prausnitzii inhibits interleukin-17 to ameliorate colorectal colitis in rats. PLoS One. 9:e109146.